BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Business

  The Scripps Research Institute Appoints Richard King As Chief Operating Officer

  June 6, 2016

   · 

  2 min read
• Biotech Bay

  Protein Metrics Pushes Biotherapeutic Development Analysis

  June 6, 2016

   · 

  2 min read
• Biotech Beach

  ASCO2016: bioTheranostics Release: New Data Presented At 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting Expand Clinical Utility Of Breast Cancer Index(SM) In The Extended Adjuvant Setting To Include Early-Stage, ER+ Patients With Up To T

  June 6, 2016

   · 

  4 min read
• Brazilian Zika Virus Research Selected As Recipient Of Johnson & Johnson Innovation, JLABS, Latin America QuickFire Challenge

  June 6, 2016

   · 

  5 min read
• BioMidwest

  BIO2016: Northeast Ohio Biomedical Companies Featured At BIO International -- The World’s Largest Biotech And Pharma Gathering

  June 6, 2016

   · 

  3 min read
• Drug Development

  ASCO2016: Merck & Co. Release: New Data For KEYTRUDA (Pembrolizumab) In Combination With Talimogene Laherparepvec, Dabrafenib Plus Trametinib, Or Low-Dose Ipilimumab In Advanced Melanoma Presented At 2016 ASCO Annual Meeting

  June 6, 2016

   · 

  17 min read
• Drug Development

  ASCO2016: Tyrogenex, Inc. Presents Data Informing Phase II And Supporting Potential Efficacy Of X-82 With Everolimus In Patients With Solid Tumors At The ASCO Annual Meeting 2016

  June 6, 2016

   · 

  2 min read
• Drug Development

  ASCO2016: Xcovery Presents Results Of Plasma Genotyping Of Patients In The Exalt2 Study At The ASCO Annual Meeting 2016

  June 6, 2016

   · 

  4 min read
• Drug Development

  ASCO2016: Bristol-Myers Squibb Release: First Presentation Of Phase II Checkmate -142 Study Evaluating Opdivo (Nivolumab) Alone Or In Combination With Yervoy (Ipilimumab) Demonstrates Encouraging Clinical Activity In MSI-High Metastatic Colorectal Cancer

  June 6, 2016

   · 

  19 min read
• Drug Development

  IgASCO2016: Ignyta Announces Interim Data From Phase 1 Clinical Trial Of Investigational Precision Medicine RXDX-105 At ASCO 2016

  June 6, 2016

   · 

  7 min read